Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
History: In the early 2000s, GLP-1-based drugs (exenatide and liraglutide) were developed for the treatment of type 2 diabetes
Exenatide extended-release (Bydureon BCise) injectable suspension
Glutathione, with its antioxidant properties, removes these toxins and stressors, helping prevent chronic diseases
To induce acute liver injury, 8-week-old NSI mice received two consecutive intraperitoneal injections of DMN (7 mg/kg, Sigma, 1.0% dissolved in saline)
[PMID: 10720752] PubMed record related to this compound for laboratory literature review
This study found no evidence reasonably suggesting an association between GLP-1RA and SSIBs based on clinical characteristics, TTO, disproportionality, and co-medication analysis
